Group One Trading
RKDA icon

Group One Trading’s Arcadia Biosciences RKDA Stock Holding History

Group One Trading’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-50
Closed -$2K – 8125
2022
Q2 		$2K Sell
50
-3
-6% -$138 ﹤0.01% 7429
2022
Q1 		$3K Buy
53
+13
+33% +$620 ﹤0.01% 7646
2021
Q4 		$2K Sell
40
-140
-78% -$9.13K ﹤0.01% 7901
2021
Q3 		$15K Buy
180
+12
+7% +$1.13K ﹤0.01% 7322
2021
Q2 		$20K Sell
168
-85
-34% -$9.27K ﹤0.01% 7193
2021
Q1 		$28K Buy
+253
New +$31K ﹤0.01% 6594

Other funds holding RKDA

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BWM
Bullock Wealth Management Bloomington, Indiana $231M AUM

Group One Trading's RKDA Position: Q2 2026 in Review

Group One Trading held its Arcadia Biosciences (RKDA) position steady in Q2 2026 at 18 shares worth $12. The position accounts for ﹤0.01% of the portfolio, ranked #7448.

Group One Trading first reported a position in RKDA in Q1 2022 and has held it in 18 quarters since. The position peaked at $23K in Q1 2022. 18 funds tracked by Wall St. Rank hold RKDA as of Q2 2026.

  • Group One Trading held 18 shares of Arcadia Biosciences worth $12 as of Q2 2026.
  • Group One Trading left its Arcadia Biosciences share count unchanged in Q2 2026.
  • Arcadia Biosciences made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7448 holding.
  • Group One Trading first reported a position in Arcadia Biosciences in Q1 2022 and has held it in 18 quarters since.
  • Group One Trading's Arcadia Biosciences position peaked at $23K in Q1 2022.
  • 18 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.